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tors, such as diabetes andObjective: To investigate associations between the provision of routine
metabolic screening and follow-up in pregnancy and participation by
primary health care centres in a large-scale continuous quality
improvement (CQI) initiative.
Design: Longitudinal analysis of 2592 audited maternal health records.
Setting and participants: Seventy-six community-controlled or
government-operated primary health care centres serving predominantly
Aboriginal and Torres Strait Islander communities, in urban, regional or
remote locations in ﬁve Australian states and territories.
Intervention: Up to four CQI cycles supported by the Audit and Best
Practice for Chronic Disease Research Partnership.
Main outcomes measures: Screening and follow-up for body mass index
(BMI), blood pressure and diabetes in pregnancy.
Results: Overall, 87.9% of women attending the participating health
centres were Aboriginal or Torres Strait Islander. Women attending a health
centre after it had conducted one or more CQI cycles were more likely to
receive BMI, blood pressure and diabetes screening. For example, the
proportion of women receiving diabetes screening at baseline (before the
ﬁrst CQI cycle) was 56.1%; after cycle 1 it was 63.7% (odds ratio [OR], 1.3;
95%CI, 1.0e1.6), after cycle 2, 61.6% (OR, 1.2; 95%CI, 0.9e1.7), after cycle 3,
63.7% (OR, 1.7; 95% CI, 1.1e2.6), and after cycle 4, 75.5% (OR, 3.4; 95% CI,
1.9e5.9). Diabetes screening was associated with higher self-ratings of
overall organisational systems (P ¼ 0.03), self-management support
(P ¼ 0.04) and organisational inﬂuence and integration (P ¼ 0.01).
Conclusion: These ﬁndings support the value of CQI approaches that focus
on systems-level issues in primary care to improve the provision of rec-
ommended pregnancy care at primary health care centres in predominantly
Aboriginal and Torres Strait Islander communities.Ahypertension during preg-
nancy, obesity and excess gestational
weight gain,1-5 is important for opti-
mising maternal and infant health
outcomes. Pregnancy is also a key
period for implementing strategies
that prevent long-term adverse
health outcomes, as excess gesta-
tional weight gain and gestational
diabetes mellitus (GDM) are respec-
tively predictors of long-term
obesity6 and the development of
type 2 diabetes.7
Screening for and follow-up of
metabolic risk factors are compo-
nents of recommended pregnancy
care in Australia.8 Ensuring that
Aboriginal and Torres Strait Islander
(respectfully referred to in this article
as Indigenous) women receive such
care is expected to contribute to
giving babies a healthy start to life
and to improving the health of their
mothers. In Australia, low birth
weight, premature birth and peri-
natal death are substantially more
frequent in Indigenous than in non-
Indigenous pregnancies.9 Obesity,
pre-existing diabetes and GDM are
some of the risk factors that are more
common in Indigenous women.3,4,10
Later in life, cardiovascular disease
and diabetes are major contributors
to the difference in life expectancy
between Indigenous and non-
Indigenous Australians.11
As care can differ between health
centres with different characteristics,
such as urban and rural or remote
locations,8 effective long-term strate-
gies are needed across a range of
settings to facilitate the provision of
all components of recommended
pregnancy care.12 TheAudit and Best
Practice for Chronic Disease (ABCD)
National Research Partnership13,14
aims to improve the provision of
care by primary health care centres(PHCs) serving mainly Indigenous
populations. It uses a continuous
quality improvement (CQI) frame-
work to increase the efﬁciency and
effectiveness of organisational sys-
tems. Previous ABCD Partnership
research indicates that increases in
self-ratings of organisational systems
are associated with improvements in
the delivery of health care for those
with type 2 diabetes.15
We investigated screening for
metabolic risk factors during preg-
nancy and follow-up actions by
PHCs participating in the ABCD
partnership. We also investigated
associations between self-ratings by
organisational systems and theMJA 203 (9) jproportion of women who undergo
metabolic screening.Methods
The study was approved by human
research ethics committees in the
relevant states and territories, and
by Indigenous subcommittees where
required.16 The analyses were
approved by the Monash University
Human Research Ethics Committee
(CF12/3434-2012001670).Study design and setting
The ABCD National Research Part-
nership study protocol has been2 November 2015 369.e1
369.e2
Researchdescribed in detail elsewhere.13,16
This partnership links multiple
PHCs and stakeholders across the
health system in collaborative CQI
research.14 One21seventy, the Na-
tional Centre for Quality Improve-
ment in Indigenous Primary Health
Care, supports CQI in PHCs by
providing evidence-based practical
tools and training.14 The ABCD
Partnership has access to One21se-
venty data from PHCs that
have volunteered to participate in
research.13,14 This article reports lon-
gitudinal analysis of data from 76
PHCs (2592 health records) involved
in the ABCD Partnership across ﬁve
Australian states and territories. The
PHCs conducted up to four CQI
cycles, comprising 58.5% (168 of 287)
of the One21seventy maternal health
audits conducted between 2007 and
2012. Twenty-one of the 76 PHCs
began maternal health auditing in
2007; 13 commenced in 2008, 13 in
2009, 11 in 2010, 10 in 2011, and 8 in
2012. Depending on their needs,
PHCs may focus in some years on
CQI activities inother clinical areas; of
50 PHCs that had completed two or
more maternal health audits, 11
(22.0%) conducted audits in non-
consecutive years.
Intervention: continuous quality
improvement cycles
At baseline, systems assessments and
audits of health records were con-
ducted and the results provided to
PHCs in real-time by an automated
CQI reporting system. PHCs use the
reports for participatory interpreta-
tion and goal setting, and this is fol-
lowed by the initiation of relevant
actions. Data collection was repeated
in subsequent years to assess success
in improving care (end of cycle 1),
and to identify new priorities for
improvement (start of cycle 2). PHCs
are encouraged to complete one cycle
each year.
Maternal health audit tool
Recorded pregnancy care was as-
sessed by auditing the health records
of women with a recent pregnancy
(mothers with an infant aged 2e14
months, who resided in the commu-
nity during their pregnancy and
attended for pregnancy care at least
once).13,16 Audits were conductedMJA 203 (9) j 2 November 2015by trained auditors (local PHC staff,
staff from other PHCs, or CQI facili-
tators) supported by a standard pro-
tocol and regional CQI facilitators.
The audit tool and parameters of the
outcome measures were based on
best practice guidelines, policy and
research reports, and stakeholder
consultations.16 At each PHC, the
auditor used a standard sampling
protocol to select a random sample of
at least 30 records to audit (if fewer
than 30 eligible records were avail-
able, all were audited).13
The Systems Assessment Tool
Structured assessments of PHC sys-
tem strengths and weaknesses were
conducted by PHC staff together
with a trained external CQI facilitator
using the Systems Assessment Tool
(SAT).13,15 This consensus process
produces a self-reported overall
mean score (range, 0e11) for the state
of development of PHC organisa-
tional systems, and ﬁve subscale
scores (delivery system design,
information systems and decision
support, self-management support,
external links, and organisational
inﬂuence and integration).
Key outcome measures
The audit tool collected information
on documentation of the following
items in each health record:16
 body weight, body mass index
(BMI) and blood pressure (BP)
screening in women attending at
earlier than 13 weeks’ gestation;
 BP checks at any point during the
pregnancy;
 a 50 or 75 gram glucose challenge
test (GCT) and, if indicated, an
oral glucose tolerance test (OGTT)
at 20e30 weeks’ gestation;
 for women with a BMI under 20
or over 30 kg/m2: development
of a BMI management plan;
 for women with high BP ( 140/
90 mmHg): repeated BP mea-
surements, urine tests for protein,
examination by or referral to a
general practitioner or obstetri-
cian, or prescription of anti-
hypertensive medication;
 an OGTT for those with an ab-
normalGCT result (plasmaglucoseconcentration 7.8mmol/L1hour
after a 50 g glucose load (morning,
non-fasting), or 8.0mmol/L after
a 75 g glucose load).
“Follow-up” in this article refers to
taking the next appropriate action
after an abnormal screening result.Statistical methods
Analyseswere conducted using Stata
version 12.1 (StataCorp). P < 0.05
(2-sided) was deﬁned as statistically
signiﬁcant. Differences in screening
proportions at baseline and at the
ﬁnal auditwere assessedwith respect
to PHC governance, location, popu-
lation size (t tests or ManneWhitney
U tests) and state or territory
(one-way analysis of variance or
KruskaleWallis tests). Paired t tests
assessed differences between the ﬁrst
and last SAT scores. Using each
health record as the unit of analysis,
random effects logistic regression
analysis (generating odds ratios)
assessed any associations between
metabolic screening and CQI cycle
number (Stata xtlogit command).
Random effects logistic regression
allowed for repeated measures of
each outcome (eg, did a patient
receive a BP check: yes or no) at each
cycle per PHC. This method also
allowed for adjustment for similar-
ities in womenwithin each PHC. The
reference group comprised audit
data from the PHCs before they had
conducted a CQI cycle (ie, cycle 0 or
baseline). We also tested for a trend
to increased metabolic screening
with each additional CQI cycle (Stata
nptrend command).
For each PHC, the proportion of
women receiving screening after
each CQI cycle was calculated.
Treating each PHC as the unit of
analysis, univariable linear regres-
sion (generating b coefﬁcients)
assessed associations between:
 the average proportion of women
who underwent screening across
all cycles, and average overall or
subscale SAT scores;
 the total change (from ﬁrst to
ﬁnal cycle) in the proportion
of women who underwent
screening, and the total change in
overall or subscale SAT scores.
ResearchResults
A range of PHC settings were
included in the study. Most women
who attended these PHCs for preg-
nancy care were Indigenous Austra-
lians (87.9%) (Box 1).
While most women who attended
during the ﬁrst trimester were
weighed, the BMI was calculated
for less than a third; but women
attending after the PHC had con-
ducted at least one CQI cycle were
more likely to have had their BMI1 Characteristics of the 76 primary h
study, and of the 2592 women wh
Characteristics of the primary health care
Governance structure
Government-operated
Community-controlled
Location
Remote
Urban or regional
Service population size
 1000 people
< 1000 people
State or territory
Northern Territory
Queensland
Western Australia
New South Wales
South Australia
Characteristics of the women
Indigenous status*
Aboriginal
Torres Strait Islander
Aboriginal and Torres Strait Islander
Age†
Median, years
< 20 years
20e34 years
 35 years
First attendance for pregnancy care occur
before 13 weeks’ gestation‡
Median number of pregnancy care visits
IQR ¼ interquartile range. * n ¼ 2435 (data missing
women). ‡ n ¼ 2591 (data missing for 1 woman).uassessed than women attending
PHCs that had not done so. Similar
patternswere observed for BP checks
at any point during the pregnancy
and diabetes screening. Improve-
ments in screening appeared to be
sustained over sequential CQI cycles,
and there were trends for additional
improvements with each additional
cycle (Box 2).
At baseline, the only signiﬁcant
differences in screening were those
between states and territories for
ﬁrst trimester BP checks (P ¼ 0.04),ealth care centres included in the
ose records were audited
centres
49 (64.5%)
27 (35.5%)
56 (73.7%)
20 (26.3)
39 (51.3%)
37 (48.7%)
28 (36.8%)
27 (35.5%)
11 (14.5%)
6 (7.9%)
4 (5.3%)
2141 (87.9%)
2028 (83.3%)
57 (2.3%)
56 (2.3%)
24.4 (IQR, 20.6e29.6)
545 (21.1%)
1807 (69.9%)
233 (9.0%)
red 1321 (51.0%)
7 (IQR, 5e10)
for 157 women). † n ¼ 2585 (data missing for 7BP checks at any stage of the preg-
nancy (P ¼ 0.02) and diabetes
screening (P ¼ 0.002). These differ-
ences were not signiﬁcant at the
PHCs’ ﬁnal audits (all P > 0.05).
There were also indications of sus-
tained improvements in the provi-
sion of follow-up actions after CQI
participation, but the sample sizes
were too small for statistical analysis.
Follow-up actions for high BP
included repeated BP assessment
(pre-26 weeks, 88.1%; post-26 weeks,
91.9%), urine tests (pre-26 weeks,
88.1%,post-26weeks, 83.9%), referral
(pre-26 weeks, 85.7% post-26 weeks,
94.3%) and antihypertensive medi-
cation (pre-26 weeks, 42.9%, post-26
weeks, 26.4%). Follow-up OGTTs
were reported for most women who
received an abnormal GCT result.
Few women with an abnormal BMI,
however, had a documented BMI
management plan (Box 3).
Systems assessment data were avail-
able for 35 PHCs (46.1%); data were
available for more than one time
point for 21. The mean overall SAT
score at the ﬁnal cycle (7.36) was
statistically signiﬁcantly higher than
at the ﬁrst cycle (6.23; P ¼ 0.009), but
there were no signiﬁcant differences
in SAT subscale scores between the
ﬁrst and ﬁnal cycles (data not
shown). Higher average self-ratings
of some organisational systems
were associated with greater provi-
sion of metabolic screening (Box 4).
For example, the average provision
of ﬁrst trimester BP screeningwas 3.7
percentage points higher for each
additional point scored on the SAT
information systems and decision
support domain. Diabetes screening
was associated with higher overall
self-ratings, as well as with higher
ratings of self-management support
systems, and of organisational inﬂu-
ence and integration.
In addition, there was a statistically
signiﬁcant association between a
one-point increase from ﬁrst to ﬁnal
assessment in information systems
and decision support scores and an
increase of 5.7 percentage points in
the proportion of women receiving
diabetes screening between the ﬁrst
and ﬁnal audits (b ¼ 5.7; 95% CI,
0.6e10.9; P ¼ 0.03). However, noMJA 203 (9) j 2 November 2015 369.e3
2 Documented metabolic screening during pregnancy after completion of each continuous quality
improvement (CQI) cycle, and associations between metabolic screening and primary health care centre
(PHC) participation in each CQI cycle
CQI cycle
P
(for trend)
0 1 2 3 4
Metabolic screening 76 PHCs 50 PHCs 28 PHCs 8 PHCs 6 PHCs
Weight measured in
ﬁrst trimester (1321 women)
440/562
(78.3%)
344/418
(82.3%)
153/202
(75.7%)
49/65
(75.4%)
56/74
(75.7%)
Odds ratio (95% CI) 1.0 1.4 (0.9e2.0)
P ¼ 0.10
1.0 (0.6e1.6)
P ¼ 0.89
1.2 (0.6e2.4)
P ¼ 0.59
1.4 (0.7e2.8)
P ¼ 0.34
0.38
BMI calculated in ﬁrst
trimester (1321 women)
132/562
(23.5%)
126/418
(30.1%)
63/202
(31.2%)
25/65
(38.5%)
31/74
(41.9%)
Odds ratio (95% CI) 1.0 2.4 (1.6e3.5)
P < 0.001
3.4 (2.0e5.6)
P < 0.001
5.1 (2.4e10.7)
P < 0.001
9.4 (4.6e19.4)
P < 0.001
<0.001
Blood pressure check in ﬁrst
trimester (1321 women)
485/562
(86.3%)
370/418
(88.5%)
180/202
(89.1%)
56/65
(86.2%)
59/74
(79.7%)
Odds ratio (95% CI) 1.0 1.3 (0.8e1.9)
P ¼ 0.27
1.5 (0.9e2.7)
P ¼ 0.15
1.6 (0.7e3.7)
P ¼ 0.24
1.1 (0.5e2.3)
P ¼ 0.78
0.51
Blood pressure check at
any point during the
pregnancy (2592 women)
1123/1201
(93.5%)
745/758
(98.3%)
383/388
(98.7%)
131/135
(97.0%)
110/110
(100.0%)
Odds ratio (95% CI) 1.0 3.7 (1.9e7.3)
P < 0.001
7.0 (2.5e19.4)
P < 0.001
2.0 (0.6e6.5)
P ¼ 0.25
— <0.001
Diabetes screening
(2541 women)*
669/1192
(56.1%)
469/736
(63.7%)
234/380
(61.6%)
86/135
(63.7%)
74/98
(75.5%)
Odds ratio (95% CI) 1.0 1.3 (1.0e1.6)
P ¼ 0.04
1.2 (0.9e1.7)
P ¼ 0.15
1.7 (1.1e2.6)
P ¼ 0.02
3.4 (1.9e5.9)
P < 0.001
<0.001
BMI ¼ body mass index. * In 2010, the audit tool was reﬁned to include “not applicable” if women had already been diagnosed with diabetes, or were
offered but declined BMI or blood pressure assessment or diabetes screening. Since 2010, 26 women were recorded as having pre-existing diabetes, and
25 women declined diabetes screening. This reduced the denominator for diabetes screening to 2541. There were no recorded instances of women
declining BMI or blood pressure checks.u
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Researchother signiﬁcant associations be-
tween changes in SAT scores and
screening were detected (data not
shown).Discussion
This large longitudinal study of
PHCs found substantial improve-
ments in routine metabolic screening
in pregnancy associated with parti-
cipation in a CQI initiative. Im-
provements were sustained over
multiple cycles, with evidence for
additional improvements with each
consecutive CQI cycle. Initiation of
follow-up actions also improved af-
ter CQI participation. Higher self-
ratings of some organisational sys-
tems were signiﬁcantly associated
with greater metabolic screening.
Screening at baseline was incomplete
for all the metabolic risk factors
investigated, consistent with reportsMJA 203 (9) j 2 November 2015from other Indigenous commu-
nities.17 It is unclear whether meta-
bolic screening coverage in other
maternity care settings is incomplete,
as this information is not reported
in other routine perinatal data col-
lections. However, improvements
associated with CQI participation
were observed with respect to BMI
and BP assessment and screening for
diabetes during pregnancy. Meas-
urement of BMI early in pregnancy is
important because maternal and
neonatal morbidity increases with
maternal BMI,3 and the recom-
mended gestational weight gain
depends on the BMI category.1 Mea-
surement of BMI may be inﬂuenced
by both the mothers’ and health
professionals’ understanding of the
importance of healthy gestational
weight gain and awareness of weight
gain guidelines, and by the conﬁ-
dence of health professionals that
they can discuss weight with womenwithout causing undue concern.18
It is encouraging that we encoun-
tered no instances of women who
declined to be weighed. Similarly,
ﬁrst trimester BP assessment and
universal second trimester GDM
screening are also recommended in
Australia, and these remain areas for
improvement. It is important to
explore potential barriers to GDM
screening, both because the preva-
lence of diabetes during pregnancy
is higher among Indigenous women
than in non-Indigenous women4 and
because of the importance of diabetes
management during pregnancy.4
Pregnancy is an opportune time for
health practitioners to discussweight
management with women.19 How-
ever, few women in this study with
an abnormal BMI had amanagement
plan, which may reﬂect suboptimal
action taken, a lack of documentation
of the actions taken, or both. Excess
weight gain increases pregnancy
3 Recorded metabolic abnormalities during pregnancy and subsequent follow-up after each continuous
quality improvement (CQI) cycle
CQI cycle
0 1 2 3 4
Metabolic risk factors and follow-up 76 PHCs 50 PHCs 28 PHCs 8 PHCs 6 PHCs
Abnormal BMI in ﬁrst trimester
(377 women)
39/132 (29.6%) 34/126 (27.0%) 17/63 (27.0%) 5/25 (20.0%) 8/31 (25.8%)
BMI management plan (103 women) 6/39 (15.4%) 10/34 (29.4%) 6/17 (35.3%) 4/5 (80.0%) 4/8 (50.0%)
High blood pressure in ﬁrst trimester
(1150 women)
11/485 (2.3%) 12/370 (3.2%) 5/180 (2.8%) 1/56 (1.8%) 0/59
Blood pressure follow-up <26 weeks
(73 women)
13/32 (40.6%) 17/27 (63.0%) 7/9 (77.8%) 2/2 (100.0%) 3/3 (100.0%)
High blood pressure at any time
during pregnancy (2492 women)
72/1123 (6.4%) 51/745 (6.8%) 25/383 (6.5%) 2/131 (1.5%) 8/110 (7.3%)
Blood pressure follow-up 26 weeks
(110 women)
34/49 (69.4%) 30/35 (85.7%) 17/20 (85.0%) no cases 6/6 (100.0%)
Abnormal GCT result (1530 women) 120/667 (18.0%) 92/469 (19.6%) 41/234 (17.5%) 15/86 (17.4%) 9/74 (12.2%)
Follow-up OGTT (277 women) 104/120 (86.7%) 81/92 (88.0%) 40/41 (97.6%) 14/15 (93.3%) 7/9 (77.8%)
PHC ¼ primary health care centre; BMI ¼ body mass index; GCT ¼ glucose challenge test; OGTT ¼ oral glucose tolerance test.u
Researchrisks, such as macrosomia, preterm
birth and the need for caesarean de-
livery,1 as well as the long-term risk
of obesity,6 making active manage-
ment vital for the wellbeing of
mother and child. Potential barriers
to developing weight management
plans include limited resources for
referral, food security concerns, and
inadequate staff time, especially in
remote communities. Development
of resources or programs for gesta-
tional weight management tailored
to the needs of Indigenous women
may assist.4 Associations between the average
scores (across all cycles) for 35 pr
Overall
score
BMI calculated in ﬁrst
trimester
4.2 (3.5 to 11.
Blood pressure check in
ﬁrst trimester
2.6 (0.6 to 5
Blood pressure check
at any point during
pregnancy
0.9 (0.9 to 2
Diabetes screening 5.3* (0.6 to 10
BMI ¼ body mass index. * P < 0.05.uMostwomenwith an abnormalGCT
result subsequently underwent a
diagnostic OGTT. Recent contro-
versy about diabetes screening20
may have created barriers to
screening and follow-up. While
large-scale implementation of the
International Association of Dia-
betes in Pregnancy Study Group
guidelines, starting in 2015,21 may
partially resolve these problems, the
number of women diagnosed with
GDM will also increase,22 with po-
tential resource implications for
PHCs.proportions of women undergoingmeta
imary health care centres (b-coefﬁcien
Delivery
system
design
Information
systems
and decision
support
9) 2.7 (4.8 to 10.2) 5.5 (1.3 to 12.2)
.8) 1.9 (1.3 to 5.0) 3.7* (0.9 to 6.4)
.6) 0.5 (1.2 to 2.2) 1.3 (0.2 to 2.9)
.1) 4.6 (0.1 to 9.3) 3.8 (0.6 to 8.2)The positive associations between
self-ratings of organisational systems
and ﬁrst trimester BP and diabetes
screening in our study support tar-
geting of organisational systems as a
strategy for improving the provision
of metabolic screening during preg-
nancy. However, further large-scale
improvements in systems and pro-
cesses that support health pro-
fessionals in conducting metabolic
screening and management are vital
if the long-term consequences of
these complications in pregnancy are
to be reduced. We hope that ourbolic screening and average Systems Assessment Tool
t, 95% CI)
Self-
management
support External links
Organisational
inﬂuence and
integration
3.5 (1.6 to 8.6) 1.9 (4.5 to 8.4) 1.2 (5.1 to 7.4)
1.5 (0.6 to 3.7) 0.6 (3.4 to 2.1) 2.5 (0.0 to 5.1)
0.3 (0.9 to 1.5) 0.3 (1.2 to 1.8) 0.7 (0.8 to 2.1)
3.4* (0.2 to 6.7) 1.2 (3.1 to 5.4) 4.9* (1.1 to 8.6)
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Researchﬁndings encourage further discus-
sion about how pregnancy care for
Indigenous women might be
improved. All levels of the health
system have roles to play, and
systems-based research networks,
such as the ABCD Partnership, are
ideally placed to develop appro-
priate strategies.
Our studywas limited by the fact that
SAT data were available for only
some PHCs (35 of 76, 46.1%),
reducing the statistical power of our
analysis to detect associations. Selec-
tion bias was also possible, as this
study included only the One21se-
venty PHCs that volunteered their
data for research (58.5% of the audits
conductedoverall).Ourdatamaynot
be representative of PHCs not
participating in the One21seventy
initiative, but this extensive network
includes a large population, and
there are currently no other compar-
able data sources in Australia. Bias
caused by the possibility that PHCs
with lesser improvement would be
less likely to remain in the CQI
initiative is difﬁcult to gauge, as
commencement years varied and
PHCs may have conducted maternal
health audits in non-consecutive
years. However, the generalisability
of our results may have been
enhanced by the fact that PHCs usedMJA 203 (9) j 2 November 2015the audit tool according to their
needs, rather than as a research
requirement. As we performed mul-
tiple statistical tests, there was a risk
of ﬁnding signiﬁcant associations by
chance. This possibility was reduced
bynot undertaking statistical tests for
follow-up actions, as the small
numbers involved were inadequate
for meaningful comparisons.
The CQI initiative continues, and
further assessment of its effects on
service delivery and health outcomes
is planned as the sample size in-
creases. Future directions include
investigating the effects on service
provision of the audit year, the year
of commencement, and the duration
of CQI participation. A cluster
randomised controlled trial is an
alternative studydesign that couldbe
used to test hypotheses arising from
the current ﬁndings.
Despite the limitations, our study has
signiﬁcant strengths that increase the
generalisability of its ﬁndings. Most
previous CQI research in pregnancy
care has been hospital-based, imple-
mented in a single service, not
focused on metabolic screening, or
not conducted in Australia.23-25 Our
research applied a unique system-
wide participatory approach to
assess systemic issues commonlyaffecting provision of care.14 It used a
detailed, longitudinal dataset to
investigate long-term sustainability,
and included many PHCs across
several settings.
Our study shows the potential of a
CQI initiative supported by a
systems-based research network to
improve the provision of recom-
mended pregnancy care at PHCs
attended by Indigenous women.
These ﬁndings are encouraging, and
suggest a successful approach for
achieving further improvement in
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